Status:
COMPLETED
IIT2020-20-SHIRAZIP-WALK: Nature Walks
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Breast Cancer
Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine whether nature-based activities provide benefits for breast cancer survivors. The investigators want to know whether a nature-based exercise program is feasible...
Detailed Description
This is a single-arm pilot study MAIN STUDY Breast cancer survivors (n=20) will engage in three months of moderate intensity walking sessions three times a week in a nature and park conservation area...
Eligibility Criteria
Inclusion
- Main Breast Cancer Study
- Female previously diagnosed with breast cancer (clinical stages 1 - 3)
- Minimum of 3 months post-active treatment completion
- Maximum of 21 months post-active treatment completion
- Physically able to complete baseline fitness assessments (e.g., 6-minute walk test, hand grip test, 1 RM leg press)
- Ambulatory without assistance
- Main Breast Cancer Study
Exclusion
- Active treatment planned within the next 6 months.
- Known metastatic disease.
- Currently meeting physical activity guidelines (score of \>23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire).
- Known allergy to Fitbit device or otherwise unable to wear Fitbit device.
- Sub-study AYA Inclusion Criteria:
- Men and women between age of 18 to 39
- Previously diagnosed with cancer
- Same inclusion criteria as the main study
- Sub-Study AYA
Key Trial Info
Start Date :
June 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04896580
Start Date
June 21 2021
End Date
May 18 2023
Last Update
February 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90069